High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients

Abstract

Due to high immunogenicity and safety of mRNA vaccines, we strongly recommend prioritizing a two-dose vaccination of dialysis patients. A third dose can be required in non-responders to two doses. When possible, patients waiting for a kidney transplantation should be offered the vaccine before transplantation.